Trial Profile
RAPID EC - Randomized Controlled Trial Assessing Pregnancy With Intrauterine Devices for Emergency Contraception
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jul 2022
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary) ; Copper
- Indications Pregnancy
- Focus Therapeutic Use
- 01 Jul 2021 Results of secondary analysis assessing pregnancy risk after intrauterine device (IUD) placement by the number and timing of unprotected intercourse episodes in the prior 14 days published in the Obstetrics and Gynecology
- 12 Jun 2021 Results of secondary analysis, quantifying sexual intercourse practices and backup contraception use following levonorgestrel IUS or CuT380A IUD placement and to calculate the risk of pregnancy in users who resume intercourse within one week of device placement, published in the Contraception
- 25 Apr 2021 Status changed from active, no longer recruiting to completed.